mdgroup Listed Among the UK’s Fastest-Scaling Firms in Organic Growth 25 Index

mdgroup, a leading global medtech and patient health services company pioneering a patient-first approach to clinical research, has been named as one of the UK's fastest-scaling businesses in 2021's Organic Growth 25 (OG25) index in recognition of its major growth and success, without significant external investment.

mdgroup, which provides digital and patient health services which put patients at the forefront of clinical trials, has evolved to meet the changing needs of the clinical research industry at an unprecedented rate. The company’s 2021 achievements include supporting the uptake of decentralized clinical trials, growing and developing its mobile health division, and launching medical distribution centers in the EU and North America to carry out clinical trial visits in patients’ own homes.

Its impressive organic growth has been recognized by accountancy and HR consultancy firm Buzzacott, which compiled the list.

This is the second year the OG25 has been assembled using companies’ revenue growth as a percentage: it reveals that mdgroup grew sales from £12.8 million in 2017 to £25.7 million in 2020 and increased headcount from 42 to 89 over the same period.

“We are delighted with our inclusion in Buzzacott’s Organic Growth 25 as it honors the accomplishments of our remarkable team over the past 12 months,” says Tarquin Scadding-Hunt, CEO of mdgroup.

“We are investing hugely in research and development, creating innovative healthcare technology that tackles the ongoing challenges our clients face at each stage of a clinical trial.

“The COVID-19 pandemic has pushed a patient-centered approach to the top of big pharma’s agenda, and it has never been more important to listen to patient voices at every stage of the clinical journey.

“From issues with patient care and sentiment to home healthcare provider visits and medical equipment to burdensome payment workflows and reimbursements, mdgroup’s pioneering technology directly improves patient experience and trial outcomes.”

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!

  • <<
  • >>

Join the Discussion